ArticlebioRxiv : the preprint server for biology2025

Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles.

Gianna T Busch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.